DIABRISK-SL prevention of cardio-metabolic disease with life style modification in young urban Sri Lankan's--study protocol for a randomized controlled trial.

Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

Original Publication: [London] : BioMed Central, 2006-

Clinical Protocols* ; Life Style*; Cardiovascular Diseases/*prevention & control ; Diabetes Mellitus, Type 2/*prevention & control; Adolescent ; Adult ; Child ; Child, Preschool ; Female ; Humans ; Male ; Research Design ; Sri Lanka

Background: Urban South-Asian's are predisposed to early onset of type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD). There is an urgent need for country specific primary prevention strategies to address the growing burden of cardio-metabolic disease in this population. The aim of this clinical trial is to evaluate whether intensive (3-monthly) lifestyle modification advice is superior to a less-intensive (12 monthly; control group) lifestyle modification advice on a primary composite cardio-metabolic end point in 'at risk' urban subjects aged between 5-40 years.
Methods/design: This is an open randomised controlled parallel group clinical trial performed at a single centre in Colombo, Sri-Lanka. A cluster sampling strategy was used to select a large representative sample of subjects aged between 5-40 years at high risk of T2DM and CVD for the intervention study. We have screened 23,298 (males 47% females 53%) healthy subjects for four risk factors: obesity, elevated waist circumference, family history of diabetes and physical inactivity, using a questionnaire and anthropometry. Those with two or more risk-factors were recruited to the intervention trial. We aim to recruit 4600 subjects for the intervention trial. The primary composite cardio-metabolic end point is; new onset T2DM, impaired glucose tolerance, impaired fasting glycaemia, new onset hypertension and albuminuria, following 5 years of intervention. The effect of the intervention on pre-specified secondary endpoints will also be evaluated. The study will be conducted according to good clinical and ethical practice, data analysis and reporting guidelines.
Discussion: DIABRISK-SL is a large population based trial to evaluate the prevalence of diabetes, pre-diabetes and cardio-metabolic risk factors among young urban Sri-Lankans and the effect of a primary prevention strategy on cardio-metabolic disease end points. This work will enable country specific and regional cardio-metabolic risk scores to be derived. Further if the proposed intervention is successful the results of this study can be translated and implemented as a low-cost primary prevention tool in Sri-Lanka and other low/middle income developing countries.
Trial Registration: The trial is registered with the World Health Organisation and Sri-Lanka clinical trial registry number SLCTR/2008/003.

Diabetes Care. 2007 Oct;30(10):2548-52. (PMID: 17670917)
Diabetologia. 2010 Apr;53(4):600-5. (PMID: 20012011)
Lancet. 2006 Nov 11;368(9548):1673-9. (PMID: 17098085)
Diabet Med. 2008 Sep;25(9):1062-9. (PMID: 19183311)
Am J Health Promot. 1997 Sep-Oct;12(1):38-48. (PMID: 10170434)
Hypertension. 2003 Dec;42(6):1206-52. (PMID: 14656957)
BMJ. 2007 Feb 10;334(7588):299. (PMID: 17237299)
Pediatrics. 1976 Aug;58(2):259-63. (PMID: 951142)
Health Psychol. 1994 Jan;13(1):39-46. (PMID: 8168470)
Diabetes Care. 2003 Nov;26(11):3160-7. (PMID: 14578255)
N Engl J Med. 2002 Feb 7;346(6):393-403. (PMID: 11832527)
Pediatr Diabetes. 2007 Oct;8(5):299-306. (PMID: 17850473)
Diabetologia. 2006 Feb;49(2):289-97. (PMID: 16391903)
BMJ. 2000 May 6;320(7244):1240-3. (PMID: 10797032)
Ann Intern Med. 1999 Mar 16;130(6):461-70. (PMID: 10075613)
J Health Soc Behav. 1983 Dec;24(4):385-96. (PMID: 6668417)
N Engl J Med. 2001 May 3;344(18):1343-50. (PMID: 11333990)
Bull World Health Organ. 2007 Sep;85(9):660-7. (PMID: 18026621)
Lancet. 2010 Jan 30;375(9712):408-18. (PMID: 19875164)
Lancet. 2007 Dec 8;370(9603):1881-2. (PMID: 18063030)
Diabet Med. 2006 May;23(5):469-80. (PMID: 16681555)
Lancet. 2008 May 24;371(9626):1783-9. (PMID: 18502303)
Nat Rev Cardiol. 2009 Nov;6(11):723-7. (PMID: 19851350)
J Gen Intern Med. 2001 Sep;16(9):606-13. (PMID: 11556941)
World Health Organ Tech Rep Ser. 2000;894:i-xii, 1-253. (PMID: 11234459)
Diabetologia. 1985 Jul;28(7):412-9. (PMID: 3899825)

Date Created: 20110928 Date Completed: 20120202 Latest Revision: 20211020

20231215

PMC3197497

10.1186/1745-6215-12-209

21943067